Global AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Market 2026 by Company, Regions, Type and Application, Forecast to 2032
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software by Type
- 1.3.1 Overview: Global AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Market Size by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Global AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Consumption Value Market Share by Type in 2025
- 1.3.3 Non-Contrast CT Software
- 1.3.4 CT Angiography Software
- 1.3.5 CT Perfusion Software
- 1.3.6 MRI Software
- 1.4 Classification of AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software by Types of Stroke
- 1.4.1 Overview: Global AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Market Size by Types of Stroke: 2021 Versus 2025 Versus 2032
- 1.4.2 Global AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Consumption Value Market Share by Types of Stroke in 2025
- 1.4.3 Ischemic Stroke Analysis Software
- 1.4.4 Hemorrhagic Stroke Analysis Software
- 1.4.5 Comprehensive Stroke Analysis Software
- 1.5 Global AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Market by Application
- 1.5.1 Overview: Global AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Market Size by Application: 2021 Versus 2025 Versus 2032
- 1.5.2 Pre-Hospital Emergency Care
- 1.5.3 Hospital Stroke Center
- 1.5.4 Primary Healthcare Institutions
- 1.5.5 Regional Stroke Collaborative Treatment Network
- 1.6 Global AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Market Size & Forecast
- 1.7 Global AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Market Size and Forecast by Region
- 1.7.1 Global AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Market Size by Region: 2021 VS 2025 VS 2032
- 1.7.2 Global AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Market Size by Region, (2021-2032)
- 1.7.3 North America AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Market Size and Prospect (2021-2032)
- 1.7.4 Europe AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Market Size and Prospect (2021-2032)
- 1.7.5 Asia-Pacific AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Market Size and Prospect (2021-2032)
- 1.7.6 South America AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Market Size and Prospect (2021-2032)
- 1.7.7 Middle East & Africa AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Market Size and Prospect (2021-2032)
2 Company Profiles
- 2.1 RapidAI
- 2.1.1 RapidAI Details
- 2.1.2 RapidAI Major Business
- 2.1.3 RapidAI AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Product and Solutions
- 2.1.4 RapidAI AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 RapidAI Recent Developments and Future Plans
- 2.2 Viz.ai
- 2.2.1 Viz.ai Details
- 2.2.2 Viz.ai Major Business
- 2.2.3 Viz.ai AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Product and Solutions
- 2.2.4 Viz.ai AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Viz.ai Recent Developments and Future Plans
- 2.3 Brainomix
- 2.3.1 Brainomix Details
- 2.3.2 Brainomix Major Business
- 2.3.3 Brainomix AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Product and Solutions
- 2.3.4 Brainomix AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Brainomix Recent Developments and Future Plans
- 2.4 Aidoc
- 2.4.1 Aidoc Details
- 2.4.2 Aidoc Major Business
- 2.4.3 Aidoc AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Product and Solutions
- 2.4.4 Aidoc AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Aidoc Recent Developments and Future Plans
- 2.5 JLK
- 2.5.1 JLK Details
- 2.5.2 JLK Major Business
- 2.5.3 JLK AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Product and Solutions
- 2.5.4 JLK AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 JLK Recent Developments and Future Plans
- 2.6 Qure.ai
- 2.6.1 Qure.ai Details
- 2.6.2 Qure.ai Major Business
- 2.6.3 Qure.ai AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Product and Solutions
- 2.6.4 Qure.ai AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 Qure.ai Recent Developments and Future Plans
- 2.7 United Imaging Intelligence
- 2.7.1 United Imaging Intelligence Details
- 2.7.2 United Imaging Intelligence Major Business
- 2.7.3 United Imaging Intelligence AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Product and Solutions
- 2.7.4 United Imaging Intelligence AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 United Imaging Intelligence Recent Developments and Future Plans
- 2.8 Infervision
- 2.8.1 Infervision Details
- 2.8.2 Infervision Major Business
- 2.8.3 Infervision AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Product and Solutions
- 2.8.4 Infervision AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue, Gross Margin and Market Share (2021-2026)
- 2.8.5 Infervision Recent Developments and Future Plans
- 2.9 Shukun Technology
- 2.9.1 Shukun Technology Details
- 2.9.2 Shukun Technology Major Business
- 2.9.3 Shukun Technology AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Product and Solutions
- 2.9.4 Shukun Technology AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue, Gross Margin and Market Share (2021-2026)
- 2.9.5 Shukun Technology Recent Developments and Future Plans
- 2.10 Heuron
- 2.10.1 Heuron Details
- 2.10.2 Heuron Major Business
- 2.10.3 Heuron AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Product and Solutions
- 2.10.4 Heuron AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue, Gross Margin and Market Share (2021-2026)
- 2.10.5 Heuron Recent Developments and Future Plans
- 2.11 Siemens Healthineers
- 2.11.1 Siemens Healthineers Details
- 2.11.2 Siemens Healthineers Major Business
- 2.11.3 Siemens Healthineers AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Product and Solutions
- 2.11.4 Siemens Healthineers AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue, Gross Margin and Market Share (2021-2026)
- 2.11.5 Siemens Healthineers Recent Developments and Future Plans
- 2.12 Circle CVI
- 2.12.1 Circle CVI Details
- 2.12.2 Circle CVI Major Business
- 2.12.3 Circle CVI AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Product and Solutions
- 2.12.4 Circle CVI AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue, Gross Margin and Market Share (2021-2026)
- 2.12.5 Circle CVI Recent Developments and Future Plans
- 2.13 Avicenna.AI
- 2.13.1 Avicenna.AI Details
- 2.13.2 Avicenna.AI Major Business
- 2.13.3 Avicenna.AI AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Product and Solutions
- 2.13.4 Avicenna.AI AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue, Gross Margin and Market Share (2021-2026)
- 2.13.5 Avicenna.AI Recent Developments and Future Plans
- 2.14 Nicolab
- 2.14.1 Nicolab Details
- 2.14.2 Nicolab Major Business
- 2.14.3 Nicolab AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Product and Solutions
- 2.14.4 Nicolab AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue, Gross Margin and Market Share (2021-2026)
- 2.14.5 Nicolab Recent Developments and Future Plans
- 2.15 icometrix
- 2.15.1 icometrix Details
- 2.15.2 icometrix Major Business
- 2.15.3 icometrix AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Product and Solutions
- 2.15.4 icometrix AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue, Gross Margin and Market Share (2021-2026)
- 2.15.5 icometrix Recent Developments and Future Plans
- 2.16 Harrison.ai
- 2.16.1 Harrison.ai Details
- 2.16.2 Harrison.ai Major Business
- 2.16.3 Harrison.ai AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Product and Solutions
- 2.16.4 Harrison.ai AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue, Gross Margin and Market Share (2021-2026)
- 2.16.5 Harrison.ai Recent Developments and Future Plans
- 2.17 Deepwise
- 2.17.1 Deepwise Details
- 2.17.2 Deepwise Major Business
- 2.17.3 Deepwise AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Product and Solutions
- 2.17.4 Deepwise AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue, Gross Margin and Market Share (2021-2026)
- 2.17.5 Deepwise Recent Developments and Future Plans
- 2.18 Neusoft Medical
- 2.18.1 Neusoft Medical Details
- 2.18.2 Neusoft Medical Major Business
- 2.18.3 Neusoft Medical AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Product and Solutions
- 2.18.4 Neusoft Medical AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue, Gross Margin and Market Share (2021-2026)
- 2.18.5 Neusoft Medical Recent Developments and Future Plans
- 2.19 BioMind
- 2.19.1 BioMind Details
- 2.19.2 BioMind Major Business
- 2.19.3 BioMind AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Product and Solutions
- 2.19.4 BioMind AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue, Gross Margin and Market Share (2021-2026)
- 2.19.5 BioMind Recent Developments and Future Plans
- 2.20 GE HealthCare
- 2.20.1 GE HealthCare Details
- 2.20.2 GE HealthCare Major Business
- 2.20.3 GE HealthCare AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Product and Solutions
- 2.20.4 GE HealthCare AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue, Gross Margin and Market Share (2021-2026)
- 2.20.5 GE HealthCare Recent Developments and Future Plans
- 2.21 Philips
- 2.21.1 Philips Details
- 2.21.2 Philips Major Business
- 2.21.3 Philips AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Product and Solutions
- 2.21.4 Philips AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue, Gross Margin and Market Share (2021-2026)
- 2.21.5 Philips Recent Developments and Future Plans
- 2.22 Olea Medical
- 2.22.1 Olea Medical Details
- 2.22.2 Olea Medical Major Business
- 2.22.3 Olea Medical AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Product and Solutions
- 2.22.4 Olea Medical AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue, Gross Margin and Market Share (2021-2026)
- 2.22.5 Olea Medical Recent Developments and Future Plans
- 2.23 Methinks AI
- 2.23.1 Methinks AI Details
- 2.23.2 Methinks AI Major Business
- 2.23.3 Methinks AI AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Product and Solutions
- 2.23.4 Methinks AI AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue, Gross Margin and Market Share (2021-2026)
- 2.23.5 Methinks AI Recent Developments and Future Plans
- 2.24 Cercare Medical
- 2.24.1 Cercare Medical Details
- 2.24.2 Cercare Medical Major Business
- 2.24.3 Cercare Medical AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Product and Solutions
- 2.24.4 Cercare Medical AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue, Gross Margin and Market Share (2021-2026)
- 2.24.5 Cercare Medical Recent Developments and Future Plans
- 2.25 PurpleAI
- 2.25.1 PurpleAI Details
- 2.25.2 PurpleAI Major Business
- 2.25.3 PurpleAI AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Product and Solutions
- 2.25.4 PurpleAI AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue, Gross Margin and Market Share (2021-2026)
- 2.25.5 PurpleAI Recent Developments and Future Plans
- 2.26 Coreline Soft
- 2.26.1 Coreline Soft Details
- 2.26.2 Coreline Soft Major Business
- 2.26.3 Coreline Soft AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Product and Solutions
- 2.26.4 Coreline Soft AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue, Gross Margin and Market Share (2021-2026)
- 2.26.5 Coreline Soft Recent Developments and Future Plans
- 2.27 mlHealth 360
- 2.27.1 mlHealth 360 Details
- 2.27.2 mlHealth 360 Major Business
- 2.27.3 mlHealth 360 AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Product and Solutions
- 2.27.4 mlHealth 360 AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue, Gross Margin and Market Share (2021-2026)
- 2.27.5 mlHealth 360 Recent Developments and Future Plans
- 2.28 NeuroCareAI
- 2.28.1 NeuroCareAI Details
- 2.28.2 NeuroCareAI Major Business
- 2.28.3 NeuroCareAI AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Product and Solutions
- 2.28.4 NeuroCareAI AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue, Gross Margin and Market Share (2021-2026)
- 2.28.5 NeuroCareAI Recent Developments and Future Plans
- 2.29 DEEPNOID
- 2.29.1 DEEPNOID Details
- 2.29.2 DEEPNOID Major Business
- 2.29.3 DEEPNOID AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Product and Solutions
- 2.29.4 DEEPNOID AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue, Gross Margin and Market Share (2021-2026)
- 2.29.5 DEEPNOID Recent Developments and Future Plans
- 2.30 Yiwei Medical
- 2.30.1 Yiwei Medical Details
- 2.30.2 Yiwei Medical Major Business
- 2.30.3 Yiwei Medical AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Product and Solutions
- 2.30.4 Yiwei Medical AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue, Gross Margin and Market Share (2021-2026)
- 2.30.5 Yiwei Medical Recent Developments and Future Plans
- 2.31 UnionStrong
- 2.31.1 UnionStrong Details
- 2.31.2 UnionStrong Major Business
- 2.31.3 UnionStrong AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Product and Solutions
- 2.31.4 UnionStrong AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue, Gross Margin and Market Share (2021-2026)
- 2.31.5 UnionStrong Recent Developments and Future Plans
- 2.32 Cerebriu
- 2.32.1 Cerebriu Details
- 2.32.2 Cerebriu Major Business
- 2.32.3 Cerebriu AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Product and Solutions
- 2.32.4 Cerebriu AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue, Gross Margin and Market Share (2021-2026)
- 2.32.5 Cerebriu Recent Developments and Future Plans
- 2.33 BrainScan
- 2.33.1 BrainScan Details
- 2.33.2 BrainScan Major Business
- 2.33.3 BrainScan AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Product and Solutions
- 2.33.4 BrainScan AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue, Gross Margin and Market Share (2021-2026)
- 2.33.5 BrainScan Recent Developments and Future Plans
- 2.34 EverFortune.AI
- 2.34.1 EverFortune.AI Details
- 2.34.2 EverFortune.AI Major Business
- 2.34.3 EverFortune.AI AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Product and Solutions
- 2.34.4 EverFortune.AI AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue, Gross Margin and Market Share (2021-2026)
- 2.34.5 EverFortune.AI Recent Developments and Future Plans
- 2.35 Nunaps
- 2.35.1 Nunaps Details
- 2.35.2 Nunaps Major Business
- 2.35.3 Nunaps AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Product and Solutions
- 2.35.4 Nunaps AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue, Gross Margin and Market Share (2021-2026)
- 2.35.5 Nunaps Recent Developments and Future Plans
- 2.36 SberMedAI
- 2.36.1 SberMedAI Details
- 2.36.2 SberMedAI Major Business
- 2.36.3 SberMedAI AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Product and Solutions
- 2.36.4 SberMedAI AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue, Gross Margin and Market Share (2021-2026)
- 2.36.5 SberMedAI Recent Developments and Future Plans
- 2.37 NtechLab
- 2.37.1 NtechLab Details
- 2.37.2 NtechLab Major Business
- 2.37.3 NtechLab AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Product and Solutions
- 2.37.4 NtechLab AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue, Gross Margin and Market Share (2021-2026)
- 2.37.5 NtechLab Recent Developments and Future Plans
- 2.38 Celsus
- 2.38.1 Celsus Details
- 2.38.2 Celsus Major Business
- 2.38.3 Celsus AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Product and Solutions
- 2.38.4 Celsus AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue, Gross Margin and Market Share (2021-2026)
- 2.38.5 Celsus Recent Developments and Future Plans
- 2.39 Third Opinion
- 2.39.1 Third Opinion Details
- 2.39.2 Third Opinion Major Business
- 2.39.3 Third Opinion AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Product and Solutions
- 2.39.4 Third Opinion AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue, Gross Margin and Market Share (2021-2026)
- 2.39.5 Third Opinion Recent Developments and Future Plans
- 2.40 Hevi AI
- 2.40.1 Hevi AI Details
- 2.40.2 Hevi AI Major Business
- 2.40.3 Hevi AI AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Product and Solutions
- 2.40.4 Hevi AI AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue, Gross Margin and Market Share (2021-2026)
- 2.40.5 Hevi AI Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Revenue and Share by Players (2021-2026)
- 3.2 Market Share Analysis (2025)
- 3.2.1 Market Share of AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software by Company Revenue
- 3.2.2 Top 3 AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Players Market Share in 2025
- 3.2.3 Top 6 AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Players Market Share in 2025
- 3.3 AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Market: Overall Company Footprint Analysis
- 3.3.1 AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Market: Region Footprint
- 3.3.2 AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Market: Company Product Type Footprint
- 3.3.3 AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Consumption Value and Market Share by Type (2021-2026)
- 4.2 Global AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Market Forecast by Type (2027-2032)
5 Market Size Segment by Application
- 5.1 Global AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Consumption Value Market Share by Application (2021-2026)
- 5.2 Global AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Market Forecast by Application (2027-2032)
6 North America
- 6.1 North America AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Consumption Value by Type (2021-2032)
- 6.2 North America AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Market Size by Application (2021-2032)
- 6.3 North America AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Market Size by Country
- 6.3.1 North America AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Consumption Value by Country (2021-2032)
- 6.3.2 United States AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Market Size and Forecast (2021-2032)
- 6.3.3 Canada AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Market Size and Forecast (2021-2032)
- 6.3.4 Mexico AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Market Size and Forecast (2021-2032)
7 Europe
- 7.1 Europe AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Consumption Value by Type (2021-2032)
- 7.2 Europe AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Consumption Value by Application (2021-2032)
- 7.3 Europe AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Market Size by Country
- 7.3.1 Europe AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Consumption Value by Country (2021-2032)
- 7.3.2 Germany AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Market Size and Forecast (2021-2032)
- 7.3.3 France AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Market Size and Forecast (2021-2032)
- 7.3.4 United Kingdom AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Market Size and Forecast (2021-2032)
- 7.3.5 Russia AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Market Size and Forecast (2021-2032)
- 7.3.6 Italy AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Market Size and Forecast (2021-2032)
8 Asia-Pacific
- 8.1 Asia-Pacific AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Consumption Value by Type (2021-2032)
- 8.2 Asia-Pacific AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Consumption Value by Application (2021-2032)
- 8.3 Asia-Pacific AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Market Size by Region
- 8.3.1 Asia-Pacific AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Consumption Value by Region (2021-2032)
- 8.3.2 China AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Market Size and Forecast (2021-2032)
- 8.3.3 Japan AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Market Size and Forecast (2021-2032)
- 8.3.4 South Korea AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Market Size and Forecast (2021-2032)
- 8.3.5 India AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Market Size and Forecast (2021-2032)
- 8.3.6 Southeast Asia AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Market Size and Forecast (2021-2032)
- 8.3.7 Australia AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Market Size and Forecast (2021-2032)
9 South America
- 9.1 South America AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Consumption Value by Type (2021-2032)
- 9.2 South America AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Consumption Value by Application (2021-2032)
- 9.3 South America AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Market Size by Country
- 9.3.1 South America AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Consumption Value by Country (2021-2032)
- 9.3.2 Brazil AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Market Size and Forecast (2021-2032)
- 9.3.3 Argentina AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Market Size and Forecast (2021-2032)
10 Middle East & Africa
- 10.1 Middle East & Africa AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Consumption Value by Type (2021-2032)
- 10.2 Middle East & Africa AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Consumption Value by Application (2021-2032)
- 10.3 Middle East & Africa AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Market Size by Country
- 10.3.1 Middle East & Africa AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Consumption Value by Country (2021-2032)
- 10.3.2 Turkey AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Market Size and Forecast (2021-2032)
- 10.3.3 Saudi Arabia AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Market Size and Forecast (2021-2032)
- 10.3.4 UAE AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Market Size and Forecast (2021-2032)
11 Market Dynamics
- 11.1 AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Market Drivers
- 11.2 AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Market Restraints
- 11.3 AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
12 Industry Chain Analysis
- 12.1 AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Industry Chain
- 12.2 AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Upstream Analysis
- 12.3 AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Midstream Analysis
- 12.4 AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
According to our (Global Info Research) latest study, the global AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software market size was valued at US$ 204 million in 2025 and is forecast to a readjusted size of US$ 344 million by 2032 with a CAGR of 6.2% during review period.
The market covers AI-enabled medical software used to analyze acute stroke imaging and support time-sensitive clinical decisions across non-contrast CT, CT angiography, CT perfusion and MRI workflows. Products typically apply machine learning or related computational methods to identify and quantify intracranial hemorrhage, ischemic change and vessel occlusion, calculate ASPECTS, characterize perfusion and tissue viability, prioritize urgent cases, and support thrombolysis, thrombectomy and interhospital transfer decisions. The market is centered on regulated clinical software deployed through hospital imaging systems, cloud or edge infrastructure, dedicated workstations and mobile workflow applications. It includes standalone algorithms and multimodule stroke platforms whose economic value is generated from diagnostic imaging analysis, decision support and stroke-network workflow coordination.
Report Scope
This report is a detailed and comprehensive analysis for global AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software market size and forecasts, in consumption value ($ Million), 2021-2032
Global AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include RapidAI, Viz.ai, Brainomix, Aidoc, JLK, Qure.ai, United Imaging Intelligence, Infervision, Shukun Technology, Heuron, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segmentation
Market segment by Type
Non-Contrast CT Software
CT Angiography Software
CT Perfusion Software
MRI Software
Market segment by Types of Stroke
Ischemic Stroke Analysis Software
Hemorrhagic Stroke Analysis Software
Comprehensive Stroke Analysis Software
Market segment by Application
Pre-Hospital Emergency Care
Hospital Stroke Center
Primary Healthcare Institutions
Regional Stroke Collaborative Treatment Network
Market segment by players, this report covers
RapidAI
Viz.ai
Brainomix
Aidoc
JLK
Qure.ai
United Imaging Intelligence
Infervision
Shukun Technology
Heuron
Siemens Healthineers
Circle CVI
Avicenna.AI
Nicolab
icometrix
Harrison.ai
Deepwise
Neusoft Medical
BioMind
GE HealthCare
Philips
Olea Medical
Methinks AI
Cercare Medical
PurpleAI
Coreline Soft
mlHealth 360
NeuroCareAI
DEEPNOID
Yiwei Medical
UnionStrong
Cerebriu
BrainScan
EverFortune.AI
Nunaps
SberMedAI
NtechLab
Celsus
Third Opinion
Hevi AI
CerebraAI
Sciberia
Radiomics & Machines
Sirona Medical
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter Outline
Chapter 1, to describe AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software, with revenue, gross margin, and global market share of AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software from 2021 to 2026.
Chapter 3, the AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software.
Chapter 13, to describe AI-Enabled Stroke Imaging Analysis and Clinical Decision Support Software research findings and conclusion.